ProShares Ultra Nasdaq Biotechnology (BIB) Leveraged/Inverse
$109.80
▼ -0.67 (-0.61%)
1-day change
$62.04 – $126.40
52-week range
Holdings data is not available for this fund yet.
BIB Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -9.84% | ▼ -9.78% |
| 3M | ▲ +2.77% | ▲ +2.84% |
| 6M | ▲ +34.28% | ▲ +34.37% |
| YTD | ▲ +37.63% | ▲ +37.74% |
| 1Y | ▲ +73.21% | ▲ +73.64% |
| 3Y | ▲ +135.47% | ▲ +142.03% |
| 5Y | ▲ +20.16% | ▲ +23.54% |
| Max | ▲ +1362.31% | ▲ +1406.10% |
Volatility 1Y42.75%
Volatility 3Y41.86%
Max drawdown 3Y
-45.99%
Beta 3Y0.85
Sharpe 1Y*1.50
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (May 2026)
-$4.8M
Quarter ending May 2026
-$13.9M
Trailing 12 months
-$12.0M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 267 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| WaVe Life Sciences Ltd. | · | $46K | 0.06 | 6,960 | EC | SG |
| Compass Pathways plc | 20451W101 | $46K | 0.06 | 3,487 | EC | GB |
| Personalis, Inc. | 71535D106 | $44K | 0.06 | 3,869 | EC | US |
| MannKind Corp. | 56400P706 | $43K | 0.06 | 11,389 | EC | US |
| EyePoint, Inc. | 30233G209 | $42K | 0.06 | 3,062 | EC | US |
| Alvotech SA | · | $41K | 0.06 | 12,210 | EC | LU |
| Collegium Pharmaceutical, Inc. | 19459J104 | $39K | 0.05 | 1,172 | EC | US |
| Savara, Inc. | 805111101 | $39K | 0.05 | 7,524 | EC | US |
| Olema Pharmaceuticals, Inc. | 68062P106 | $39K | 0.05 | 2,962 | EC | US |
| Corvus Pharmaceuticals, Inc. | 221015100 | $38K | 0.05 | 3,054 | EC | US |
| Xeris Biopharma Holdings, Inc. | 98422E103 | $38K | 0.05 | 6,134 | EC | US |
| Absci Corp. | 00091E109 | $38K | 0.05 | 5,561 | EC | US |
| Zenas Biopharma, Inc. | 98937L105 | $36K | 0.05 | 1,983 | EC | US |
| Cullinan Therapeutics, Inc. | 230031106 | $36K | 0.05 | 2,185 | EC | US |
| Grifols SA | 398438408 | $35K | 0.05 | 4,510 | EC | ES |
| Pacira BioSciences, Inc. | 695127100 | $35K | 0.05 | 1,495 | EC | US |
| ARS Pharmaceuticals, Inc. | 82835W108 | $33K | 0.05 | 3,656 | EC | US |
| Janux Therapeutics, Inc. | 47103J105 | $33K | 0.04 | 2,251 | EC | US |
| Kura Oncology, Inc. | 50127T109 | $33K | 0.04 | 3,218 | EC | US |
| Sana Biotechnology, Inc. | 799566104 | $33K | 0.04 | 9,849 | EC | US |
| Arbutus Biopharma Corp. | 03879J100 | $32K | 0.04 | 7,110 | EC | CA |
| Xencor, Inc. | 98401F105 | $32K | 0.04 | 2,711 | EC | US |
| MeiraGTx Holdings plc | · | $32K | 0.04 | 2,975 | EC | KY |
| Amphastar Pharmaceuticals, Inc. | 03209R103 | $32K | 0.04 | 1,677 | EC | US |
| ORIC Pharmaceuticals, Inc. | 68622P109 | $31K | 0.04 | 3,711 | EC | US |
| Eton Pharmaceuticals, Inc. | 29772L108 | $30K | 0.04 | 992 | EC | US |
| Theravance Biopharma, Inc. | · | $30K | 0.04 | 1,875 | EC | KY |
| Mesoblast Ltd. | 590717401 | $30K | 0.04 | 1,934 | EC | AU |
| Geron Corp. | 374163103 | $30K | 0.04 | 23,602 | EC | US |
| Annexon, Inc. | 03589W102 | $29K | 0.04 | 5,349 | EC | US |
| Omeros Corp. | 682143102 | $29K | 0.04 | 2,622 | EC | US |
| Phathom Pharmaceuticals, Inc. | 71722W107 | $28K | 0.04 | 2,912 | EC | US |
| BioAge Labs, Inc. | 09077V100 | $28K | 0.04 | 1,604 | EC | US |
| Esperion Therapeutics, Inc. | 29664W105 | $28K | 0.04 | 8,837 | EC | US |
| Replimune Group, Inc. | 76029N106 | $27K | 0.04 | 3,053 | EC | US |
| Maravai LifeSciences Holdings, Inc. | 56600D107 | $26K | 0.04 | 5,410 | EC | US |
| CorMedix, Inc. | 21900C308 | $25K | 0.03 | 2,911 | EC | US |
| Zevra Therapeutics, Inc. | 488445206 | $24K | 0.03 | 2,083 | EC | US |
| Prime Medicine, Inc. | 74168J101 | $24K | 0.03 | 6,673 | EC | US |
| Phibro Animal Health Corp. | 71742Q106 | $23K | 0.03 | 763 | EC | US |
| Castle Biosciences, Inc. | 14843C105 | $23K | 0.03 | 1,100 | EC | US |
| Vor BioPharma, Inc. | 929033207 | $23K | 0.03 | 1,536 | EC | US |
| CytomX Therapeutics, Inc. | 23284F105 | $23K | 0.03 | 6,265 | EC | US |
| Candel Therapeutics, Inc. | 137404109 | $22K | 0.03 | 2,707 | EC | US |
| Zai Lab Ltd. | 98887Q104 | $22K | 0.03 | 1,269 | EC | KY |
| Design Therapeutics, Inc. | 25056L103 | $22K | 0.03 | 2,105 | EC | US |
| Tectonic Therapeutic, Inc. | 878972108 | $22K | 0.03 | 693 | EC | US |
| Ironwood Pharmaceuticals, Inc. | 46333X108 | $22K | 0.03 | 6,028 | EC | US |
| Arvinas, Inc. | 04335A105 | $21K | 0.03 | 2,363 | EC | US |
| Solid Biosciences, Inc. | 83422E204 | $21K | 0.03 | 2,880 | EC | US |
Dividends 13 payments
0.20%TTM yield
$0.23TTM payout / share
Quarterly
(est.)
| Ex-date | Amount / share |
|---|---|
| Sept. 23, 2026 | $0.0830 |
| March 25, 2026 | $0.0070 |
| Dec. 24, 2025 | $0.1350 |
| Sept. 24, 2025 | $0.1810 |
| June 25, 2025 | $0.1710 |
| March 26, 2025 | $0.1310 |
| Dec. 23, 2024 | $0.3960 |
| Sept. 25, 2024 | $0.1530 |
| June 26, 2024 | $0.2650 |
| March 20, 2024 | $0.0400 |
| Dec. 20, 2023 | $0.0380 |
| Dec. 22, 2022 | $0.0200 |
| Sept. 21, 2010 | $0.0110 |
Institutional owners (13F) 22 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $785,973 | 21.94% | 7,802 | Shares | June 30, 2026 |
| Capital Investment Advisors, LLC | $599,013 | 16.72% | 5,946 | Shares | June 30, 2026 |
| Kaizen Financial Strategies | $535,554 | 14.95% | 5,315 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $413,034 | 11.53% | 4,100 | Call option | June 30, 2026 |
| Palumbo Wealth Management LLC | $402,960 | 11.25% | 4,000 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $302,220 | 8.44% | 3,000 | Call option | June 30, 2026 |
| Jump Financial, LLC | $257,189 | 7.18% | 2,553 | Shares | June 30, 2026 |
| TOTH FINANCIAL ADVISORY CORP | $102,957 | 2.87% | 1,022 | Shares | June 30, 2026 |
| FRANKLIN RESOURCES INC | $70,115 | 1.96% | 696 | Shares | June 30, 2026 |
| PNC Financial Services Group, Inc. | $50,370 | 1.41% | 500 | Shares | June 30, 2026 |
| Ashton Thomas Private Wealth, LLC | $37,576 | 1.05% | 373 | Shares | June 30, 2026 |
| Truvestments Capital LLC | $12,593 | 0.35% | 125 | Shares | June 30, 2026 |
| Axiom Investment Management LLC | $5,037 | 0.14% | 50 | Shares | June 30, 2026 |
| Qube Research & Technologies Ltd | $4,936 | 0.14% | 49 | Shares | June 30, 2026 |
| SIMPLEX TRADING, LLC | $1,309 | 0.04% | 13 | Shares | June 30, 2026 |
| CHASE INVESTMENT COUNSEL CORP | $241 | 0.01% | 2,400 | Shares | June 30, 2026 |
| Rockefeller Capital Management L.P. | $201 | 0.01% | 2 | Shares | June 30, 2026 |
| MORGAN STANLEY | $131 | 0.00% | 1 | Shares | June 30, 2026 |
| UBS Group AG | $101 | 0.00% | 1 | Shares | June 30, 2026 |
| WELLS FARGO & COMPANY/MN | $65 | 0.00% | 1 | Shares | June 30, 2026 |
| Harel Insurance Investments & Financial Services Ltd. | $20 | 0.00% | 198 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $0 | 0.00% | 1 | Shares | June 30, 2026 |